What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Antibody
His primary scientific interests are in Virology, Plasmodium falciparum, Immunology, Antibody and Antigen.
His biological study spans a wide range of topics, including Vaccinia and Viral vector.
His Plasmodium falciparum study introduces a deeper knowledge of Malaria.
Immunity, Vaccination, Immune system, Immunogenicity and Immunization are among the areas of Immunology where the researcher is concentrating his efforts.
His Immunoglobulin G study in the realm of Antibody interacts with subjects such as Basigin.
Simon J. Draper focuses mostly in the field of Antigen, narrowing it down to topics relating to Neutralizing antibody and, in certain cases, Blood stage malaria, Tissue plasminogen activator and Recombinant DNA.
His most cited work include:
- Erratum: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody (642 citations)
- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA (250 citations)
- Viruses as vaccine vectors for infectious diseases and cancer (235 citations)
What are the main themes of his work throughout his whole career to date?
Simon J. Draper mainly investigates Virology, Plasmodium falciparum, Immunology, Malaria and Antigen.
His research integrates issues of Vaccinia, Malaria vaccine, Viral vector and Immunogenicity in his study of Virology.
His work deals with themes such as Antibody, Monoclonal antibody and Clinical trial, which intersect with Plasmodium falciparum.
His study in Antibody is interdisciplinary in nature, drawing from both Growth inhibition and Apical membrane antigen 1.
The Malaria study combines topics in areas such as Computational biology, Parasitology and Immunization.
His Antigen study incorporates themes from Heterologous, Vaccine efficacy, Plasmodium yoelii, Adenoviridae and Plasmodium berghei.
He most often published in these fields:
- Virology (60.47%)
- Plasmodium falciparum (52.91%)
- Immunology (44.77%)
What were the highlights of his more recent work (between 2017-2021)?
- Plasmodium falciparum (52.91%)
- Malaria (41.86%)
- Virology (60.47%)
In recent papers he was focusing on the following fields of study:
Simon J. Draper mostly deals with Plasmodium falciparum, Malaria, Virology, Antibody and Antigen.
His Plasmodium falciparum study combines topics from a wide range of disciplines, such as Parasitology, Disease, Immune system and Cell bank.
His Malaria research is multidisciplinary, incorporating perspectives in Computational biology, Gene and Immunization.
His studies deal with areas such as Clinical trial, Adjuvant, Epitope, Blood stage and Monoclonal antibody as well as Virology.
His research on Antibody concerns the broader Immunology.
His research in Antigen intersects with topics in Chemical biology, Newcastle disease and Peptide.
Between 2017 and 2021, his most popular works were:
- Malaria Vaccines: Recent Advances and New Horizons (99 citations)
- Erythroferrone inhibits the induction of hepcidin by BMP6 (87 citations)
- Engineering a Rugged Nanoscaffold to Enhance Plug-and-Display Vaccination (58 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Antibody
His scientific interests lie mostly in Antibody, Plasmodium falciparum, Malaria, Antigen and Virology.
Immunology covers Simon J. Draper research in Plasmodium falciparum.
The study incorporates disciplines such as Genome editing, Infectious disease and Genomics in addition to Malaria.
His work in Antigen tackles topics such as Immunity which are related to areas like Plasmodium knowlesi.
Simon J. Draper has researched Virology in several fields, including Cell culture, Cell bank, Immunogenicity, Adjuvant and Monoclonal antibody.
His Monoclonal antibody research is multidisciplinary, incorporating elements of Epitope and Vaccination.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
